Results for "Understanding Pharmaceutical Distribution"
HDA Announces Government Affairs and Policy Staffing Updates
The Healthcare Distribution Alliance (HDA) announces updates regarding staff leading its Government Affairs and Policy teams.
HDA Statement on Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”
HDA Recommends a Phased Approach to Implementing the Final Requirements of the DSCSA
The Healthcare Distribution Alliance (HDA) is recommending to the Food and Drug Administration (FDA) a phased approach to final implementation of the Drug Supply Chain Security Act (DSCSA) to minimize the potential for supply disruptions and interruptions to patient care. The proposal was communicated through a recent letter to FDA.
HDA Statement on FDA Commissioner Nominee Dr. Robert Califf
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.
HDA’s President and CEO Chester “Chip” Davis, Jr., Testifies Before House Energy and Commerce Health Subcommittee on Generic Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Subcommittee on Health during a legislative hearing on proposals to prevent and respond to generic drug shortages.